- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02036606
Racing and Crowded Thoughts in Mood Disorders
August 24, 2018 updated by: University Hospital, Strasbourg, France
Psychopathological and Cognitive Mechanisms of Racing and Crowded Thoughts in Mood Disorders
Racing thoughts relate to subjective acceleration of thinking which has been essentially associated with manic episodes in bipolar disorder.
Qualitatively, the phenomenology of racing thoughts in major depression seems to differ from rumination and pure manic racing thoughts: thoughts of all kinds accumulate in the patient's head.
Recent qualitative evidence is consistent with the existence of these two kinds of "thought overactivity" related to mood disorders.
In order to evaluate this and better understand the psychopathological and cognitive mechanisms that underlie thought overactivity in mood disorders, we have created a 34-item self-questionnaire - the Racing and Crowded Thoughts Questionnaire (RCTQ) and a number of neuropsychological tasks (time perception, cognitive flexibility).
Also, given the relationship between mood disorders and creativity, it is likely that thought overactivity is related to increased creativity.
We aim at evaluating this relationship through the French version of the Cognitive Processes Associated with Creativity scale (CPAC).
Study Overview
Study Type
Observational
Enrollment (Anticipated)
220
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alsace
-
Strasbourg, Alsace, France, 67091
- Recruiting
- Service de psychiatrie 2 , Les Hôpitaux Universitaires de Strasbourg
-
Contact:
- Gilles Bertschy, PHD MD
- Email: gilles.bertschy@chru-strasbourg.fr
-
Principal Investigator:
- Gilles Bertschy, PHD MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Primary care clinic
Description
Inclusion Criteria:
- Bipolar disorder or depressive disorder
- 18 -65 years old
Exclusion Criteria:
- neurological conditions or sequelae
- substance abuse in the last 10 months
- schizophrenia
- ADHD
- Borderline personality disorder
- Pregnant women- Subjects under legal supervision
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
mood disorders
Questionary and neuropsychological tasks will be administered
|
|
|
control
Questionary and neuropsychological tasks will be administered
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validation of the scale of Crowded Racing Thoughts Questionary = (RCTQ scale that assesses the two forms of racing thoughts)
Time Frame: one week
|
Demonstrated a two-factor structure (crowded and racing) assessment concurrent and discriminant validity.
|
one week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluation of executive and temporal mechanisms involved in racing thoughts
Time Frame: one week
|
one week
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Validation of the French version of the scale Cognitive Processes Associated with Creativity or CPAC scale (scale that assesses creativity)
Time Frame: one week
|
one week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Gilles Bertschy, PHDMD, Les Hopitaux Universitaires de Strasbourg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2014
Primary Completion (Anticipated)
April 1, 2019
Study Completion (Anticipated)
April 1, 2020
Study Registration Dates
First Submitted
January 6, 2014
First Submitted That Met QC Criteria
January 13, 2014
First Posted (Estimate)
January 15, 2014
Study Record Updates
Last Update Posted (Actual)
August 28, 2018
Last Update Submitted That Met QC Criteria
August 24, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5582 (OTHER: CTEP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.